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Background
Hypoxaemia, an oxygen deficiency in human blood, is a common symptom in many 
serious illnesses that mostly relate to the heart and lung (Pierson 2000). The prevalence 
of hypoxaemia in lung diseases is significant. According to European lung foundation, it 
is expected that in 2020, out of 68 million deaths worldwide, 11.9 million will be caused 
by lung diseases (Siniscalco et al. 2008). Every year an estimated 156 million new cases of 
pneumonia occur and 2 million children under the age of five years die from pneumonia 
because lack of proper treatment. According to World Health Organization (WHO), the 
median prevalence of hypoxaemia in pneumonia was 13 %, but the prevalence varied in 
different region. This corresponds to 15–27 million cases of hypoxaemic pneumonia per 
year (Subhi et al. 2009). In 2010, 300 million people were affected by asthma worldwide. 
In 2009 asthma caused 250,000 deaths globally (Brunner 2010). In a study that was con-
ducted in India, 26 % of 51 children presenting to an emergency department in India 
with asthma had hypoxaemia (Moore and Pascual 2010). Most of the 250,000 deaths 
from asthma each year can be attributed to lack of proper treatment.
Chronic obstructive pulmonary disease (COPD) affects an estimated 210 million peo-
ple worldwide (GARD 2014). It is the fourth most common cause of death in the United 
States, and it is expected that it will be the third leading cause of death in the world by 
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2030 (Abegnoli 2014). Over 80 % of the patients with advanced disease enrolled in the 
National Emphysema Treatment Trial were using some form of oxygen therapy (Kent 
et al. 2011). 90 % of COPD deaths were estimated to occur in low and middle income 
countries due to lack of proper long term oxygen treatment (European COPD Coalition 
2015). Clearly, millions of cases of lung diseases are admitted to the healthcare facilities, 
causing millions of hypoxaemic patients to be under the risk of death and disability due 
to lack of proper oxygen treatment.
Hypoxaemia is strongly associated with in-patient death and disability (Duke et  al. 
2010). This association is more dominant in underserved populations due to the high 
cost associated with oxygen therapy, and overall deficiency in well-trained healthcare 
providers. Conventionally, oxygen therapy is commonly administered in intensive care 
units (ICUs) using a desktop Pulse-Oximeter by which healthcare providers continu-
ously monitor patient’s oxygen and manually adjust the amount of supplemental oxygen 
to the hypoxaemic patient. ICUs are expensive in terms of equipment and healthcare 
delivery. Failure to admit patients with severe hypoxaemia to ICU due to bed capacity 
or misdiagnosis could lead to death or cause permanent disability. Furthermore, many 
studies have proven that excessive oxygen supplement has toxic effects (Crapo 1986; 
Fisher 1980; Jackson 1985).
To help more hypoxaemic patients to have administrated oxygen therapy in cost effec-
tive way, to reduce toxic effects of oxygen therapy, and to accelerate the process of oxy-
gen weaning, a portable automated intelligent system that continuously monitors and 
adjusts oxygen delivery is needed. Recently, few studies have addressed the process of 
automated or computerized oxygen delivery process. Investigation and testing the fea-
sibility of using an automated system for oxygen delivery was reported in Behbahani 
and Ali (2012), Lellouche and LHer (2012), Cirio and Nava (2011). These studies were 
based on using a commercial Pulse Oximeter and a developed automated computerized 
system that adjusts the oxygen flow based on a Pulse-Oximetry signal. In this work, we 
designed the Oxygen Reader Subsystem instead of using a commercial one for the fol-
lowing reasons: (1) To have control over processing the raw data with the aim to develop 
more robust algorithms that can provide higher reading accuracy for patients oxygen 
saturation and heart rate, even with patients movements and other external artifacts. (2) 
To customize our Oxygen Reader Subsystem to a wearable earlobe Pulse Oximeter with 
higher level of comfort and ease of use. (3) To implement Bluetooth technology in our 
Pulse Oximeter (Oxygen Reader Subsystem) to communicate with the Automated Oxy-
gen Delivery Subsystem that administers the oxygen delivery based on patient needs. 
(4) To own the technology. Thus, we can control and reduce the overall cost of develop-
ing the Portable Automated Oxygen Delivery Subsystem, which in turn helps to reduce 
its price for commercialized. This in turn will help more hypoxemic patients, specifi-
cally in developing countries, to be able to acquire the entire system with reasonable 
price. (5) To have more control in reducing the overall power consumption by applying 
power management techniques which will prolong the battery life for our whole system 
as power consumption is a critical design issues in portable systems.
Generally speaking, all the previous works have shown promising results as dem-
onstrated through clinical trials in terms of minimizing time of the exposure to 
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hypoxaemia, reducing the chance of toxic effect of oxygen therapy, and prolong the life 
of oxygen supply where the oxygen supply is limited.
This paper describes the development of a Portable Automated Oxygen Adminis-
tration System (PAOAS) which has two subsystems that communicate wirelessly: an 
Oxygen Reader Subsystem that measures the oxygen saturation level in human’s blood 
non-invasively, and an Automated Adjustment Oxygen Delivery Subsystem that adjusts 
the amount of supplemental oxygen for hypoxaemic patient based on his/her oxygen’s 
needs. To the best of our knowledge, this system will be the first system of its kind to be 
used in healthcare service to administer the process of oxygen therapy at hospital set-
tings, pre-clinics, and home. Furthermore, as this system is portable and small, hypoxae-
mic patient can use it continuously during all life activities.
Medical background
Oxygen is necessary for metabolic processes in human cells and tissues. Oxygen is deliv-
ered to human’s cells through the blood. Most of the oxygen (97 %) that is transported to 
blood from the lung’s alveolus is combined with the haemoglobin and (3 %) is dissolved 
in the plasma (Bukwirwa 1999a). Hypoxaemia is oxygen deficiency in arterial blood cir-
culation (Eckman 2010). Oxygen deficiency in blood can lead to hypoxia, which is oxy-
gen deficiency in tissues and cells. Tissues and cells use oxygen to perform essential life 
metabolic processes. Hypoxia affects the functionalities of cells, tissues, and organs. In 
severe cases, if not treated effectively in a timely manner, hypoxia could cause perma-
nent disability or death within few minutes.
Generally, hypoxia could occur as a consequence to one of the following causes (see 
Fig. 1): Tissues’ inability to take oxygen from the blood (metabolic poisoning) (Liesivuori 
and Savolainen 1991), environmental conditions (less oxygen in the air) (Schoene 2001), 
or the human body’s disability to extract sufficient oxygen from air or transport it to 
cells and tissues (Rao et  al. 2012). Medically, hypoxia can be classified into four types 
based on its causes as shown in Fig. 2. The oxygen content in arterial blood is affected by 
blood capacity in carrying oxygen and oxygen sufficiency in the pulmonary capillaries. 
The oxygen content of arterial blood CaO2 is described using Eq. (1) (Bukwirwa 1999b), 
where Hb is the haemoglobin concentration (g/l), SaO2 is the arterial Hb oxygen satura-
tion, and PaO2 is arterial oxygen partial pressure.
(1)CaO2 = (k1×Hb× SaO2 + (K2 × PaO2)
Hypoxia
Human body ’s disability to 
extract  sufficient oxygen 
from air or transport it to 
cells and ssues 
Tissues’ inability  to 
take oxygen from the 
blood
( metabolic poisoning) 
Environmental 
( less oxygen in the air)
Fig. 1 Main causes of hypoxia
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Oxygen delivery is affected by blood capacity in carrying oxygen, oxygen sufficiency in 
the pulmonary capillaries, and blood circulation. Global oxygen delivery is the amount 
of oxygen delivered to the whole body from the lungs. It is the product of total blood 
flow or cardiac output (CO) and the oxygen content of arterial blood ( CaO2 ) and is usu-
ally expressed in ml/min (Bukwirwa 1999b).
Hypoxaemia detection and measuring
To detect and measure the oxygen deficiency in human blood, invasive and non-invasive 
methods can be used as shown in Fig. 3. The invasive method requires a blood sample to 
be taken from patient, so, it is intrusive and impractical for continuous on-line monitor-
ing, pre-hospital settings and home. To obtain the oxygen saturation in the blood (SaO2) 
invasively (Naeije and Barberá 2001), blood gas analysis technique is used. The blood gas 
analysis is costly in terms of equipment, storage, and healthcare providers.
(2)DO2 = CO× CaO2
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On the other hand, the non-invasive method is safe, inexpensive and practical for con-
tinuous monitoring and pre-hospital settings. Pulse Oximeter was first introduced in 
1980 to monitor the SpO2 in the blood non-invasively. In this device, the oxygen satura-
tion of the capillary blood (SpO2) is measured using radiation sensing techniques (Naeije 
and Barberá 2001).
Oxygen therapy administration
Oxygen is a lifesaving medication that should be offered to hypoxaemic patient with 
administration to provide the patient with his/her oxygen needs as well as to avoid toxic 
effects of excessive oxygen supplement. Administered oxygen therapy requires monitor-
ing patient’s oxygen level as well as adjusting the amount of oxygen delivery. Up to this 
date, this process of adjusting the supplemental oxygen is conducted manually. Further-
more, the process of administering oxygen therapy continuously is just performed in 
ICU and hospital settings by healthcare providers who make their decisions by monitor-
ing the patient oxygen saturation using desktop Pulse Oximeter or blood gas analysis.
Portable Automated Oxygen Administration System (PAOAS)
To avoid improper treatment of hypoxaemic patient and overcome the limitations of 
administering oxygen therapy, in this work, we report on our development of a proto-
type model for a Portable Automated Oxygen Administration System (PAOAS).
The promising benefits of using the developed PAOAS for oxygen delivery administra-
tion to healthcare service are demonstrated by (see Fig.  4): (1) Improving the admin-
istered oxygen therapy in ICUs and hospitals settings, (2) Extending the administered 
oxygen therapy beyond the hospital settings, and (3) Overcoming the scarcity of well-
trained healthcare providers. To achieve the intended benefits of the PAOAS, the design 
goals of such a system are depicted in Fig. 5.
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Praccal for connuous 
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Fig. 3 Hypoxaemia detection and measuring methods
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In this work, the developed prototype model is capable of measuring the patient oxy-
gen saturation non-invasively and adjusting the supplemental oxygen accordingly. In 
reality, providing the hypoxaemic patient by just the required amount of oxygen in a 
timely manner will minimize and avoid the toxic effects of oxygen therapy by continu-
ously adjusting the supplemental oxygen based on his/her needs. This also will help the 
hypoxaemic patient to get the required amount of oxygen while carrying out his daily 
activities.
Description of the Portable Automated Oxygen Administering System
The developed prototype model for PAOAS is shown in Fig.  6. It has two subsystems 
that communicate wirelessly using Bluetooth technology: an Oxygen Reader Subsystem 
Improve Oxygen Therapy in 
ICU/NICU Units
Extend Oxygen Therapy 
Administraon 
Pre hospital 
Settings in Rural 
AreasEmergency Points
Home for Long 
Term and 
Portable Oxygen 
Therapy
Overcome the Huge Scarcity of 
Well Trained Healthcare 
Providers 
Portable Automated Oxygen Administraon System
Fig. 4 Promising benefits of PAOAS on healthcare services
Fig. 5 Design goals of PAOAS
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and Automated Adjustment Oxygen Delivery Subsystem. The Oxygen Reader Subsys-
tem captures the photoplethysmography (PPG) signal non-invasively in a continuous 
manner using the radiation sensing technique. The captured raw measurements are 
processed every one second in the MCU using DSP filters, and consequently oxygen 
saturation level, heart rate, and perfusion index are computed and sent wirelessly using 
Bluetooth technology to the Automated Adjustment Oxygen Delivery Subsystem. The 
computed PPGs measurements are received every one second by the Automated Adjust-
ment Oxygen Delivery Subsystem and displayed on the attached small LCD display; 
while the amount of supplemental oxygen (for hypoxaemic patients) is adjusted accord-
ingly by the closed loop proportional solenoid valve.
Description of the Oxygen Reader Subsystem
The Oxygen Reader Subsystem consists of oxygen sensor, analog front end (AFE) unit, 
microcontroller, power unit, and bluetooth module as shown in Fig.  7. The selected 
microcontroller (STM32F40xxx) for this Subsystem has the required peripherals and 
capabilities to accomplish the required tasks, such as A/D, D/A, Timers, SPI, USART, 
DSP and power management capabilities. The microcontroller reads the raw PPG signal 
from the AFE circuit, where the AFE is simply a transducer circuit and a LEDs driving 
Fig. 6 Prototype model for the Automated Oxygen Administration System
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circuit. The transducer circuit converts the low detected current from the photodiode 
of the SpO2 sensor to a readable voltage by the microcontroller’s A/D. The LEDs driving 
circuit controls switching operation and the intensities of the Red and Infra-red LEDs of 
the SpO2 sensor based on commands from the MCU.
The Oxygen Reader Subsystem was implemented by performing the tasks that are 
shown in the diagram of Fig. 8. The MCU is the main unit in the Oxygen Reader Sub-
system as it has to perform and continuously control the following operations: (1) Con-
trol the LEDs switching and intensities of the SpO2 sensor through the LEDs driving 
circuit, (2) Read the PPG signal from the SpO2 sensor through the transducer circuit, (3) 
Manipulate the PPG signal using the DSP algorithms and compute the oxygen level and 
heart rate, and (4) Send wirelessly the computed oxygen level and heart rate every one 
second using the STM32 Bluetooth module to the Automated Adjustment Subsystem. 
Each subsystem was assembled on one side of a 2.14 inch × 3.19 inch two-layer PCB 
board. For the final product, the PCB boards for the two subsystems will be smaller as 
we intend to increase the number of layers and have the components assembled on both 
sides. The Oxygen Reader Subsystem will be a wearable earlobe, and the Automated 
Adjustment Oxygen Delivery System will be a handheld device that attached to the oxy-
gen cylinder or the oxygenator.
The concept of using radiation sensing technique to compute the oxygen level in arte-
rial blood is not new as it was first introduced in 1935 when Matthes and his colleague 
developed the first oxygen saturation meter that used a 2-wavelength light source with 
red and green lights (Matthes 1935) [later changed to Red (660 nm) and Infra-red (910 
nm) lights]. The first commercialized Pulse-Oximeter was developed by Aoyagi et  al. 
(1974) and commercialized by Biox in 1981. In 2005, Masimo company released the 
newest device, Co-oximeter (ex: Rad-57 handheld) to measure the oxygen saturation 
more accurately to overcome many limitations of traditional Pulse-Oximeter (Ruckman 
2011). In this device, they used 8 different wavelengths and other algorithms to acquire 
and manipulate the data. Measuring the oxygen saturation level and the heart rate using 
radiation sensing technique is based on two basic principles: (1) The volume of blood in 
arteries changes with each heart beat (arterial blood is pulsatile in nature while venous 
blood is not), and (2) The absorption of the Hb (Deoxyhemoglobin) and HbO2 (Oxy-
hemoglobin) for Red and Infra-red lights due to color and conformation. HbO2 absorbs 
SPO2 Sensor
RED and Infrared 
LEDs
Photodiode
Signal 
Condioning
AFE 
MCU
(STM 
32F40xx )
With DSP 
instrucons 
and FPU
Power Management Unit
STM 32 
Bluetooth
Fig. 7 Design architecture of the Oxygen Reader Subsystem
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more Infra-red light than Hb which absorbs more Red light than HbO2 (Bledsoe 2012). 
When a transmissive SpO2 sensor is placed around a thin body part (such as an ear-
lobe or a fingertip), part of the transmitted Red or Infra-red signal will be absorbed by 
the thin body part (arterial, venous, tissues, and bones) (Tamura et al. 2014); the arte-
rial blood is pulsatile with systolic and diastolic phase of the cardiac cycle. The detected 
transmitted signal from the other thin body part has DC and AC components. These two 
components are used to compute the oxygen saturation level and the heart rate based 
on Beer-Lambert law that describes light attenuation through a sample of homogeneous 
non-scattering media or based on predefined calibration method that derived based on 
the experimental measurements.
In this work, The A/D converter of the MCU captures the raw signal from SpO2 sensor 
through the transducer circuit of the AFE with sampling rate equals to 500 samples per 
second. The raw measurements contain multiplexed data for the photodiode sensor for 
three different configurations: Red LED ON and Infra-red LED OFF, Red LED OFF and 
Infra-red LED OFF, and Red LED OFF and Infra-red LED ON. The LEDs driving circuit 
controls the LEDs switching sequences and their intensities through the output ports and 
Fig. 8 Tasks diagram for the Oxygen Reader Subsystem
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PWM of the MCU as shown in Fig. 9. The MCU controls switching the LEDs in the fol-
lowing sequences for Red/Infra-red LEDs: ON/OFF, OFF/OFF, OFF/ON, OFF/OFF. The 
MCU unit de-multiplexes the captured measurements of the A/D converter to Red raw 
PPG signal, Infra-red raw PPG signal, and a reference signal. This means that the sampling 
frequency for the captured Red/Infra-red PPG signal is 125 sample/second. To reduce 
the power consumption when LEDs are ON, we use a timer to turn the LEDs OFF after 
reading the corresponding measurement for the photodiode sensor from AFE circuit. The 
synchronization between switching the LEDs and capturing their corresponding measure-
ments is very important in this context to avoid capture unstable or invalid measurements.
The raw Red PPG and Infra-red PPG signals were processed using Digital FIR and IIR 
filters to obtain their AC and the DC components. The filters to extract the AC and DC 
components of the PPG signal were: (1) Second order, low pass IIR Butterworth filter with 
cut-off frequency equals to 0.1 Hz for DC tracking, (2) Fourth order, high pass IIR Butter-
worth filter with stop frequency equals to 0.1 Hz and pass frequency equals to 0.5 Hz for 
DC removal, and (3) Tenth order, Low pass FIR-Window (Kaiser window with beta = 0.5) 
filter with cut-off frequency equals to 10 Hz to remove the noise from the AC component. 
The first filter was used to track the DC component, and the other two filters were used 
in consequence to obtain the AC component and remove the noise. These filters were 
designed using filter design tool in Simulink (MATLAB), then the coefficients of these 
filters were extracted and used with DSP library from STMicroelectronics to implement 
these filters and acquire the AC and DC components of the Red PPG and Infra-red PPG 
Fig. 9 Controlling the SpO2 sensors LEDs and acquiring the conditioned transmitted light measurements 
from the SpO2 sensor
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signals. Designing these filters was conducted while considering the frequency band for 
the PPG signal, which is between 0.5 and 4.0 Hz (Carr and Brown 1998; MASIMo 2001). 
The processed PPG signal in the Oxygen Reader Subsystem is shown in Fig. 10.
Oxygen saturation (SpO2) in arterial blood is defined as the ratio of the oxyhaemoglo-
bin to the total haemoglobin as described in Eq. (3). Thus, the computation of oxygen 
level is based on measuring the intensity of the Red and Infra-red lights that are attenu-
ated by a thin body part and captured by the photodiode sensor. The captured signal is 
divided into a DC and AC components. The DC component represents the light absorp-
tion of the tissue, venous blood, and non-pulsatile arterial blood, while the AC compo-
nent represents the pulsatile arterial blood.
The measurement of the SpO2 in arterial blood is conducted by utilizing The Beer–Lam-
bert model, where the ratio of the absorbed light for two wavelengths is computed using 
Eq. (4). To compute the SpO2, either a lookup table is sued to match the computed R 
with the SpO2 or a calibration equation (SpO2 = k × R, where k can be considered from 
the calibration results; Wongjan et  al. 2009) is used. Clinical experimental measure-
ments must be used in forming the calibration equation and lookup table. The SpO2 in 
this work was computed using the empirical Eq. (5) that was formulated based on exper-
imental measurements for the published work in Mehta et al. (2012).
To compute the heart rate per minute, the sampling frequency of the PPG signals was 
multiplied by 60 s and divided by the average number of samples in each heart pulse as 
in Eq. (6).
(3)SpO2 =
HbO2
(Total Haemoglobin)
× 100%
(4)R =
ACRed
DCRed
ACInfrared
DCInfrared
(5)SPO2 = 110− (25× Ratio)
(6)HR =
Sampling rate × 60
number of samples
number of heart pulses
Fig. 10 AC part of the processed PPG signal, captured and processed in the Oxygen Reader Subsystem
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To stabilize the measurements, the weighted moving average (WMA) was used. After 
computing the SpO2, heart rate, and perfusion index every second in the Oxygen Reader 
Subsystem, these measurements are sent to the STM32 Bluetooth module utilizing the 
USART serial connection. The Bluetooth module in turn sends these measurements 
wirelessly to the automated adjustment Oxygen Delivery Subsystem.
Description of the automated adjustment Oxygen Delivery Subsystem
The hardware architecture for the Automated Adjustment Oxygen Delivery Subsystem 
consists of Bluetooth chip, 32-bit ARM Microcontroller, a small LCD display, power 
management unit,and Parker closed-loop proportional solenoid valve, as shown in 
Fig. 11.
The prototype model for the Automated Adjustment Oxygen Delivery Subsystem has 
been implemented by performing the tasks that are shown in the Diagram of Fig.  12. 
In this work, we have followed the Waterfall model (McConnell 1996) where each task 
is divided into subtasks and integrated with the other tasks and iteratively re-visited to 
release the prototype model for PAOAS.
The Automated Adjustment Oxygen Delivery Subsystem receives data from the Oxy-
gen Reader Subsystem through the Bluetooth module every one second. The received 
data is checked against predefined values. If there is no PPG readings in the received 
data, a message Please Insert your Finger appears in the LCD display as shown in 
Fig.  13a, and the proportional solenoid valve stops delivery of oxygen. If the received 
data carries PPG measurements, the (SPO2, HR, PI) will be displayed on the LCD display 
as shown in Fig. 13b. The amount of oxygen that should compensate for the oxygen defi-
ciency is determined based on the SpO2 level and predefined values for oxygen adminis-
tration. Consequently, the proportional solenoid valve will be controlled to allow specific 
defined amount of oxygen to be delivered to the hypoxaemic patient from the oxygen 
supplement. The closed-loop solenoid valve controls the flow rate of the delivered oxy-
gen from the oxygen supplement (Cylinder or Oxygenator). The amount of supplemental 
oxygen is modified every minute to consider the SpO2 level or based on other criteria for 
oxygen administration procedure. The Flowchart for the Automated Adjustment Oxy-
gen Delivery Subsystem is shown in Fig. 14.
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Fig. 11 Design architecture for the Automated Adjustment Oxygen Delivery Subsystem
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The developed prototype model for the Automated Adjustment Oxygen Delivery 
Subsystem is connected with Parker closed-loop proportional solenoid valve through 
RJ45 connector. The closed-loop proportional solenoid valve takes oxygen with pres-
sure equals to 50 PSI as input and adjusts the amount of oxygen that is provided to the 
patient at its output port. The amount of oxygen is determined by the input voltage to 
the proportional solenoid valve from the D/A convert of the MCU that determines this 
amount based on the SpO2 measurements and using oxygen administration algorithm. 
In the developed model, we used a simple algorithm to achieve a target saturation of 
94–98 % for most acutely ill patients as stated in the guidelines for oxygen prescriptions 
guide from British Thoracic Society (BTS) (Welham et  al. 2010). For the final system, 
we will implement the described algorithm in Fig. 1 of BTS Guidelines in Welham et al. 
(2010), which addresses the amount of oxygen that should be delivered to different types 
of patients based on their illness and needs.
Fig. 12 Tasks diagram for the Automated Adjustment Oxygen Delivery Subsystem
Page 14 of 18Alzoubi et al. SpringerPlus  (2016) 5:470 
Integration and testing the Portable Oxygen Administration System
The two subsystems of the Portable Oxygen Administration System were integrated 
and tested against the required functionalities. To check the capability of the developed 
Fig. 13 The LCD display showing a the message “Please Insert Your Finger”, b the SpO2, heart rate, and perfu-
sion index for the captured PPG signal
Fig. 14 Flow chart for the Automated Adjustment Oxygen Delivery Subsystem
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model in measuring the oxygen saturation level and the heart rate, measurements were 
compared to the PPG measurements from the commercial Pulse Oximeter (H100B) by 
conducting experimental measurements using the set up in Fig. 16. The experiment was 
conducted on the same person at the same time, where her fingertip of left hand was 
placed in the SpO2 sensor for the commercial Pulse Oximeter and the her fingertip of 
the right hand was placed in the SpO2 sensor of the oxygen Reader Subsystem as shown 
in Fig. 16a. Measurements were read from both system is shown in Fig. 16b. The experi-
ment was repeated on different people. The experiments showed very good agreement 
between the SpO2 and heart rate measurements from our system and from the com-
mercial Pulse-Oximeter (H100B) (see Fig.  15). The developed prototype shows good 
agreements for SpO2 and heart rate measurements when compared to the Commercial 
Pulse Oximeter. The agreement was good despite the need for our system to be cali-
brated based on experimental measurements. During next phase of this project, we will 
calibrate our developed system by conducting experimental measurements on different 
patients at hospital settings.
Challenges and limitations
Computer failure is a challenge that has to be addressed when designing medical sys-
tems. Computer-related failure can be defined as any event that causes a computer-
based medical device to function improperly or present harm to patients or users due to 
failures in any of the medical systems components including software, hardware, I/O, or 
battery. Most computer failures are software failures (Alemzadeh et al. 2013). To address 
Fig. 15 SpO2, HR, and PI using: a commercial Pulse-Oximeter, b prototype model for the Automated Oxygen 
Administration System
Fig. 16 Set up for the SpO2, HR, and PI using commercial Pulse-Oximeter and the prototype model for the 
Automated Oxygen Administration System with its two subsystems that communicate wirelessly: a Oxygen 
Reader Subsystem, b Automated Adjustment Oxygen Delivery Subsystem
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software failure in our system, we used watchdog timer mechanism to monitor if the 
system hangs or does not respond for a specific period of time because of any software 
failure. For example, if the system hangs for more than one minute, the watchdog timer 
will restart the system. Moreover, if there is a hardware failure, an alarm message will be 
displayed to notify the user.
Battery-life is another crucial factor in portable medical systems. To address the bat-
tery-life in our developed prototype model, we focused on reducing the power consump-
tion during the design phase by considering the power consumption as a critical design 
parameter. This was in addition to using different power management techniques. In 
our final product, we will use rechargeable batteries and implement more robust power 
management technique to prolong the battery life.
Summary and conclusions
In this work we investigated Oxygen therapy administration in terms of importance, 
limitations, and global burden of hypoxaemia. We provided a medical background about 
hypoxia and hypoxemia by explaining the difference between hypoxia and hypoxemia, 
defining the different sources causing hypoxia, classifying hypoxia into four different 
types based on causes, and describing how hypoxemia can be detected and measured. 
Furthermore, we defined the oxygen administration process, and provided the benefits 
of automated oxygen administration process on healthcare service and hypoxaemic 
patient’s life by having a PAOAS. To address the aforementioned needs and provide the 
hypoxaemic patient with continuous administered oxygen therapy at hospital, pre-clinic, 
and home settings, we introduced a prototype model for the PAOAS. The developed 
prototype consisted of two subsystems that communicate wirelessly using Bluetooth 
technology: an Oxygen Reader Subsystem, and Automated Adjustment Oxygen Deliv-
ery Subsystem. The prototype model measures the SpO2 and consequently adjusts the 
amount of supplemental oxygen that is delivered to the patient accordingly using sim-
ple oxygen administration algorithm. The measurements for SpO2, and heart rate from 
our system showed strong agreements with the measurements from a commercial 
Pulse Oximeter. We expect to achieve higher reading accuracy after calibrating our sys-
tem based on experimental measurements. Our final product will be small, the Oxygen 
Reader Subsystem will be wearable earlobe device and the Automated Adjustment Oxy-
gen Delivery Subsystem will be more intelligent by implementing more robust oxygen 
administration process that could help in accelerating the weaning process for patient 
who needs oxygen therapy for short-term.
The PAOAS developed in this work used Bluetooth technology for transferring data 
between its two subsystems, thus patient’s measurements can be sent to a patient’s cell 
phone using Bluetooth technology for further transfer to healthcare providers for fur-
ther monitoring and administration. By implementing an intelligent algorithm for oxy-
gen weaning process, we expect our system will help to accelerate the oxygen weaning 
process for patients who need oxygen therapy for a short term.
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